Julie C. Lively

2.5k citations

8 papers · 2.0k indexed · 1 hit paper · h-index 8

Co-authors: Raghu Kalluri Richard O. Hynes Akulapalli Sudhakar Michael Zeisberg Hikaru Sugimoto Kairbaan Hodivala‐Dilke Yohei Maeshima Louise E. Reynolds
Topics: Cell Adhesion Molecules Research (8 papers)Angiogenesis and VEGF in Cancer (6 papers)Platelet Disorders and Treatments (2 papers)
Cited by: Immunology and Allergy Cancer Research Molecular Biology
Journals: Science Proceedings of the National Academy of Sciences Nature Medicine
Partner nations: United States United Kingdom Australia

In The Last Decade

Julie C. Lively

8 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

2002 502 citations Louise E. Reynolds, Lorenza Wyder et al. Nature Medicine profile →

Peers

Countries citing papers authored by Julie C. Lively

Since Specialization

Citations

This map shows the geographic impact of Julie C. Lively's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie C. Lively with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie C. Lively more than expected).

Fields of papers citing papers by Julie C. Lively

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie C. Lively. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie C. Lively. The network helps show where Julie C. Lively may publish in the future.

Co-authorship network of co-authors of Julie C. Lively

This figure shows the co-authorship network connecting the top 25 collaborators of Julie C. Lively. A scholar is included among the top collaborators of Julie C. Lively based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie C. Lively. Julie C. Lively is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner 2011 ·Proceedings of the National Academy of Sciences ·Liang Xie,Michael B. Duncan,Jessica Pahler,Hikaru Sugimoto,(unknown),Julie C. Lively,Thomas M. Mundel,(unknown),Kristofer Rubin,Takaaki Takeda,Masahiro Inoue,Jack Lawler,Richard O. Hynes,Douglas Hanahan,Raghu Kalluri	43
2	Elevated Flk1 (Vascular Endothelial Growth Factor Receptor 2) Signaling Mediates Enhanced Angiogenesis in β3-Integrin–Deficient Mice 2004 ·Cancer Research ·Andrew R. Reynolds,Louise E. Reynolds,Tobi Nagel,Julie C. Lively,Stephen D. Robinson,Daniel J. Hicklin,Sarah Bodary,Kairbaan Hodivala‐Dilke	134
3	Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin 2003 ·Cancer Cell ·Yuki Hamano,Michael Zeisberg,Hikaru Sugimoto,Julie C. Lively,Yohei Maeshima,Changqing Yang,Richard O. Hynes,Zena Werb,Akulapalli Sudhakar,Raghu Kalluri	428
4	Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins 2003 ·Proceedings of the National Academy of Sciences ·Akulapalli Sudhakar,Hikaru Sugimoto,Changqing Yang,Julie C. Lively,Michael Zeisberg,Raghu Kalluri	390
5	Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. 2003 ·PubMed ·Changqing Yang,Michael Zeisberg,Julie C. Lively,Pia Nyberg,Nezam H. Afdhal,Raghu Kalluri	110
6	Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrinsbreakdown → 2002 ·Nature Medicine ·Louise E. Reynolds,Lorenza Wyder,Julie C. Lively,Daniela Taverna,Stephen D. Robinson,Xiaozhu Huang,Dean Sheppard,Richard O. Hynes,Kairbaan Hodivala‐Dilke	502
7	The Diverse Roles of Integrins and Their Ligands in Angiogenesis 2002 ·Cold Spring Harbor Symposia on Quantitative Biology ·Richard O. Hynes,Julie C. Lively,Joseph H. McCarty,Daniela Taverna,Sheila Francis,Kairbaan Hodivala‐Dilke,Qian Xiao	92
8	Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis 2002 ·Science ·Yohei Maeshima,Akulapalli Sudhakar,Julie C. Lively,Kohjiro Ueki,Surender Kharbanda,C. Ronald Kahn,Nahum Sonenberg,Richard O. Hynes,Raghu Kalluri	342

About Julie C. Lively

Julie C. Lively is a scholar working on Immunology and Allergy, Cancer Research and Hematology, having authored 8 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (8 papers), Angiogenesis and VEGF in Cancer (6 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Immunology and Allergy (1.0k citations), Cancer Research (769 citations) and Molecular Biology (1.3k citations). Julie C. Lively has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Raghu Kalluri, Richard O. Hynes, Akulapalli Sudhakar, Michael Zeisberg, Hikaru Sugimoto, Kairbaan Hodivala‐Dilke, Yohei Maeshima, Louise E. Reynolds, Stephen D. Robinson and Daniela Taverna. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact